Idris, T; Volgger, B; Sallinger, G; Schauer, C; Pfleger, U; Neuwirth, M; Kreische, S; Marth, C; Petru, E.
Non-acceptable Toxicity Profile in the randomized Phase-II-Study with liposomal Doxorubicin +/- Gemcitabine plus prophylactic G-CSF-Administration (AGO Austria 10) in platin-resistant Recurrent Ovarian Cancer
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science